Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Molecular Cancer Research : MCR|February 4, 2011
A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosisSutapa Sinha, Sayantani Roy, Bathula Surendar Reddy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2024
Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2-Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL TherapyMurali K Mamidi, Sutapa Sinha, Mariana T Mendez, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2022
Inflammatory Cells in Nephrectomy Tissue from Patients without and with a History of Urinary Stone DiseasePegah Dejban, Elena M Wilson, Muthuvel Jayachandran, et al.
Blood Neoplasia|June 2, 2025
Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemiaOlivia M Depies, Qianqian Guo, Yuan Gao, et al.
Oncotarget|January 17, 2019
Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapySutapa Sinha, Justin C Boysen, Kari G Chaffee, et al.
Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric studyMingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Leukemia|April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activityMichelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.
Cancer Immunology Research|June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T CellsR Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.
Blood|April 21, 2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLLWei Ding, Betsy R LaPlant, Timothy G Call, et al.
Pageof 3